Demand for point-of-care messaging likely increasing.
It’s clear to us that physicians and patients need the messaging and support from our pharma partners that our technology provides. Our point-of-care delivery is an important digital touchpoint needed for virtual visits such as telehealth and video chat. We are in contact with many brands strategizing the right messages needed on the front lines now.
As we move into the next phase of our national strategy to combat the epidemic, physicians and patients need specific support.
- Given the impact of COVID-19 on unemployment, patient affordability messaging will become more critical than ever.
- As many patients continue to stay home, they will not be able to interact with their healthcare team. Our messaging, such as Refill Alerts, can positively impact adherence and provide an Rx lift as more patients transition to a 90-day supply.
- Our Brand Messaging communications can help combat the decline in field sales access and continue to drive awareness with high-value HCPs.
We’re all in this together. We should be proud of our medicines and technology have already had such a positive impact as we battle this epidemic. Our continued innovation will lead us through the recovery.
We’re proud to have the opportunity to do our part in helping get through this crisis.
We were able to immediately launch a free interactive text message service to provide coronavirus information issued by the Centers for Disease Control and Prevention (CDC) directly to any SMS-enabled mobile device. To date, consumers in 49 states have signed up and are using this service.
We launched TelaRep, an in-workflow option for providers to connect virtually with MSLs and reps.
How should your brand digitally show up differently now? We can help you navigate a plan based on the latest data using your strategy and existing digital communication plans – whether in the EHR or not.
Contact us to see how we can work together to make sure HCPs have the information they need, and patients have access to treatment during these trying times.
 Study: Physicians changing prescribing habits, embracing telemedicine during COVID-19 crisis, Medical, Marketing and Media, April 20, 2020
 Monitoring the Impact of COVID-19 on the Pharmaceutical Market, IQVIA, Published April 17, 2020, Data week ending April 3, 2020